MEI Pharma, Inc.
MEIPNASDAQHealthcare
$3.07
+$0.29(+10.43%)
Market Cap$20452012
P/E Ratio—
52W High$9
52W Low$1.46
MEI Pharma, Inc. (MEIP) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MEIP · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.07B | $0.05B | $0.04B | $0.03B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.06B | $0.05B | $0.04B | $0.02B |
| Gross Margin %(computed) | — | 99.41% | 96.28% | 100.00% | 94.49% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.02B | $0.05B | $0.09B | $0.07B |
| G&A Expenses | $0.01B | $0.02B | $0.03B | $0.03B | $0.02B |
| Total Operating Expenses | $0.02B | $0.03B | $0.04B | $0.12B | $0.09B |
| Operating Income | ($0.02B) | $0.01B | ($0.04B) | ($0.08B) | ($0.06B) |
| Operating Margin %(computed) | — | 22.27% | -75.31% | -185.48% | -236.63% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.02B) | $0.02B | ($0.03B) | ($0.05B) | ($0.04B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.02B) | $0.02B | ($0.03B) | ($0.05B) | ($0.04B) |
| Net Margin %(computed) | — | 27.23% | -65.22% | -133.79% | -161.78% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.39 | $2.67 | $-4.78 | $-8.75 | $-7.34 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| EBITDA | ($0.02B) | $0.03B | ($0.03B) | ($0.08B) | ($0.06B) |
| EBITDA Margin %(computed) | — | 40.40% | -67.15% | -184.68% | -235.52% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more MEI Pharma, Inc. data
About MEI Pharma, Inc. (MEIP) Income Statement
MEI Pharma, Inc. (MEIP) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MEIP reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.02B) — a net profit margin of —.
Frequently asked questions
MEIP · 4 questionsMEI Pharma, Inc. (MEIP) reported revenue of $0.00B for 2025, down 100.0% year-over-year.
MEIP revenueMEIP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09